Tải bản đầy đủ (.pdf) (1 trang)

báo cáo hóa học: " Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer" pot

Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (130.64 KB, 1 trang )

COR R E C T I ON Open Access
Estimation of minimally important differences in
EQ-5D utility and VAS scores in cancer
A Simon Pickard
1*
, Maureen P Neary
2
, David Cella
3
Correction
We wish to correct a mistake in the abstract and con-
clusion of our published paper [1]. In the a bstract and
conclusion, the MID for EQ-VAS score should be
reported as 7 rather than 0.07. EQ-VAS scores range
from 0 to 100, while EQ-5D index-based scores are
anchored by 0 (dead) and 1 (perfect health). The specific
wording in the conclusion of the abstract should read
“Important differences in EQ-5D utility and VAS scores
were similar for all cancers and lung cancer, with the
lower end of the range of estimates closer to the MID, i.
e. 0.08 for UK-index scores, 0.06 for US-index score s,
and 7 for VAS scores.
Author details
1
Center for Pharmacoeconomic Research, Department of Pharmacy Practice,
College of Pharmacy, University of Illinois at Chicago, Chicago, USA.
2
Global
Health Outcomes, GlaxoSmithKline, Collegeville, Pennsylvania, USA.
3
Center


for Outcomes Research and Education, Evanston Healthcare and Feinberg
School of Medicine, Northwestern University, Chicago, USA.
Received: 30 December 2009
Accepted: 13 January 2010 Published: 13 January 2010
References
1. Pickard AS, Neary MP, Cella D: Estimation of minimally important
differences in EQ-5D utility and VAS scores in cancer. Health Qual Life
Outcomes 2007, 5:70.
doi:10.1186/1477-7525-8-4
Cite this article as: Pickard et al.: Estimation of minimally important
differences in EQ-5D utility and VAS scores in cancer. Health and Quality
of Life Outcomes 2010 8:4.
Publish with Bio Med Central and every
scientist can read your work free of charge
"BioMed Central will be the most significant development for
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central
yours — you keep the copyright
Submit your manuscript here:
/>BioMedcentral
* Correspondence:
1
Center for Pharmacoeconomic Research, Department of Pharmacy Practice,
College of Pharmacy, University of Illinois at Chicago, Chicago, USA
Pickard et al. Health and Quality of Life Outcomes 2010, 8:4
/>© 2010 Pickar d et al; licensee BioMed Cent ral Ltd. This is an Open Ac cess article distributed under the terms of the Crea tive Commons

Attribu tion License (h ttp://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.

×